Jun Y.
About Jun Y.
Jun Y. serves as the Chief Financial Officer at Structure Therapeutics, a position he has held since 2022. He has extensive experience in the biotechnology sector, having previously worked as Chief Operating Officer and co-founder at the same company, as well as in various leadership roles at other organizations.
Work at Structure Therapeutics
Jun Y. serves as the Chief Financial Officer at Structure Therapeutics, a position he has held since 2022. In this role, he is responsible for overseeing the financial operations and strategic financial planning of the company. Prior to this, he was the Chief Operating Officer and Co-founder of Structure Therapeutics from 2016 to 2022, where he contributed to the company's growth and operational strategies in the San Francisco Bay Area.
Previous Experience in Corporate Development
Before joining Structure Therapeutics, Jun Y. worked as Vice President of Corporate Development at Cellerant Therapeutics from 2010 to 2016. In this capacity, he focused on corporate strategy and partnerships, enhancing the company's market position. His earlier experience includes serving as Sr. Director of Licensing & Business Development at VIA Pharmaceuticals from 2004 to 2010, where he managed licensing agreements and business growth initiatives.
Research Background
Jun Y. began his career in research at The Scripps Research Institute, where he worked from 1999 to 2000. This role provided him with foundational experience in scientific research, contributing to his understanding of the biotechnology field. His research experience complements his later roles in corporate development and financial management.
Education and Expertise
Jun Y. holds a Bachelor's Degree in Molecular Cell Biology from the University of California, Berkeley. His educational background in molecular biology supports his expertise in the biotechnology sector, bridging the gap between scientific research and business development.